Agilent Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioinformatics Pipelines
07 Junho 2022 - 11:35AM
Business Wire
Cloud-native Alissa data analysis SaaS platform empowers
clinical labs and researchers to scale operations with parallel
analysis of genomic data
Agilent Technologies Inc. (NYSE: A), a global leader in genomics
technology, today announced it will use Amazon Elastic Compute
Cloud (Amazon EC2) G5g instances powered by Amazon Web Services
(AWS) Graviton2 processors and featuring NVIDIA T4G Tensor Core
GPUs, in combination with NVIDIA Clara Parabricks’ advanced
genomics analysis capabilities, to significantly improve processing
speeds for variant calling workflows on Agilent’s cloud-native
Alissa Reporter software.
This collaboration enables Agilent to offer streamlined workflow
solutions for its SureSelect family of next-generation sequencing
(NGS) assays comprising a wide range of custom and catalog panels,
including SureSelect Human Exome reagents. The integration of
NVIDIA Clara Parabricks platform with the Alissa secondary analysis
pipelines enables clinical labs and researchers to benefit from
fast panel-specific data analysis solutions in a secure and
user-friendly cloud software environment.
“Agilent’s SureSelect panels are widely utilized to enrich
samples for specific genes of interest, enabling cost-effective
targeted sequencing. We’re now able to leverage our bioinformatics
expertise, in combination with NVIDIA’s compute expertise, to offer
our customers optimized analysis solutions through a combination of
Agilent’s optimized variant calling algorithms and NVIDIA’s
accelerated compute capabilities,” said Kevin Meldrum, Vice
President and General Manager of Agilent’s Integrated Genomics
Division.
“We’re also excited to extend our collaboration with AWS to
further leverage its data security capabilities and global reach,
so we can offer cloud-based analysis capabilities to customers on a
global basis,” Meldrum added.
“As the scale and scope of genomics experiments accelerates,
reducing analysis turnaround times is more important than ever,”
said George Vacek, Global Director of Genomics Alliances at NVIDIA.
“The integration of NVIDIA Clara Parabricks with Agilent’s Alissa
Reporter software package will enable clinical labs and researchers
to improve the efficiency and costs associated with NGS data
analysis, helping to advance genomics discovery and medicine.”
“Working with Agilent and NVIDIA, we are giving genomics
customers worldwide the ability to take advantage of and innovation
with AWS’s secure and transformative cloud computing capabilities
that offer the best cost and performance globally. Running genomics
workloads in the cloud, allows customers to focus on the important
work they are doing to speed insights and achieve scientific
breakthroughs that uncover novel and lifesaving products,” said
Ankit Malhotra, Genomics Lead, Healthcare, Worldwide Public Sector
at Amazon Web Services. “We look forward to our continuing
collaboration with both companies to help advance genomic
discoveries supported by the cloud. Agilent is committed to working
with AWS and NVIDIA to continually advance genomic data analysis
capabilities, including region-specific adaptations to meet local
security and compliance criteria.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the
life sciences, diagnostics, and applied chemical markets,
delivering insight and innovation that advance the quality of life.
Agilent’s full range of solutions includes instruments, software,
services, and expertise that provide trusted answers to our
customers' most challenging questions. The company generated
revenue of $6.32 billion in fiscal 2021 and employs 17,000 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, please
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn,
Twitter, and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220607006006/en/
Media Contact Naomi Goumillout Agilent Technologies
+1.781.266.2819 naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024